| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |